It has been reported that a study conducted in Israel revealed that the vaccine jointly developed by Pfizer-BioNTech is 70 percent effective against the Delta variant of the new type of corona virus (Covid19).
Israel Public Broadcasting Corporation (KAN) has published the results of the Hebrew University’s research on the efficacy of the Pfizer-BionNTech vaccine against the Delta variant.
It was noted that the result of the research showed that the vaccine developed jointly by Pfizer-BioNTech was 70 percent effective against the Delta variant.
In the study, it was also stated that the effect of the vaccine in preventing serious symptoms in people infected with the Delta variant was lower than its effect against other variants.
Previous research in Israel has revealed that the Pfizer-BioNTech vaccine is 95 percent effective against other variants of Covid-19.
It was noted that people who received the vaccine did not show many symptoms, even if they were infected with other variants of Covid-19.